Verastem Oncology Reports First Quarter 2019 Financial Results
Company Reports $1.7 Million in Net Product Revenues from COPIKTRA™; Issues Product Revenue Guidance for 2019 Cash, Cash Equivalents and…
Pharmaceuticals, Biotechnology and Life Sciences
Company Reports $1.7 Million in Net Product Revenues from COPIKTRA™; Issues Product Revenue Guidance for 2019 Cash, Cash Equivalents and…
Conference call begins today at 4:30 p.m. Eastern time EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company…
— Initiated Screening of Participants to Enroll in the PHYOX™2 Phase 2 Pivotal Trial of DCR-PHXC for the Treatment of…
– Top-line Data from INVICTUS Pivotal Phase 3 Clinical Study of Ripretinib in Fourth-line and Fourth-line Plus GIST Patients Expected…
Positive OpRegen® Data Presented at Association for Research in Vision and Ophthalmology Annual Meeting Announced Issuance of New Patent for…
– Conference Call Today at 4:30 p.m. ET – SEATTLE–(BUSINESS WIRE)–Omeros Corporation (NASDAQ: OMER), a commercial-stage biopharmaceutical company committed to…
– Company will host a conference call and webcast at 5:00 pm ET today – CAMBRIDGE, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24SYBX&src=ctag" target="_blank"gt;$SYBXlt;/agt;…
– $13 million raised in 1H19 – – Norovirus bivalent vaccine Phase 1b clinical study underway with results expected in…
PITTSBURGH–(BUSINESS WIRE)–Noveome Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular…
Topline results in the previously treated EGFR cohort (cohort 1) of the poziotinib ZENITH20 trial are expected in Q4 2019.…